0001181431-13-018093.txt : 20130320 0001181431-13-018093.hdr.sgml : 20130320 20130320173050 ACCESSION NUMBER: 0001181431-13-018093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130318 FILED AS OF DATE: 20130320 DATE AS OF CHANGE: 20130320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: S&R Technology Holdings, LLC CENTRAL INDEX KEY: 0001384384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 13705874 BUSINESS ADDRESS: STREET 1: 7501 WISCONSIN AVENUE STREET 2: SUITE 600E CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019418111 MAIL ADDRESS: STREET 1: 7501 WISCONSIN AVENUE STREET 2: SUITE 600E CITY: BETHESDA STATE: MD ZIP: 20814 4 1 rrd374805.xml FORM 4 X0306 4 2013-03-18 0 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001384384 S&R Technology Holdings, LLC 7501 WISCONSIN AVENUE SUITE 600E BETHESDA MD 20814-6519 0 0 1 0 Class A Common Stock 2013-03-18 4 S 0 38462 5.2836 D 25400808 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2012. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.39, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Kei Tolliver, Executive Vice President 2013-03-20